Is Amazon Gearing Up to Sell Prescription Drugs?
There has been speculation that Amazon is looking to join the pharmacy business. CNBC reported that the business has discussed the idea over the last few years and it has hired a new general manager to formulate a strategy. Amazon has been moving more into the healthcare space, as it has started selling medical supplies and equipment, and a few months ago hired Mark Lyons away from Premera Blue Cross.
How to Make a High-Risk Pool Work
High-risk pools are gaining a lot of attention since the House GOP health plan would let states receive waivers to create such pools. Opponents of the bill have pointed to failed high-risk pools in the past, but one state has made it work: Maine. A Kaiser Health News article has highlighted what it was about the Maine high-risk pool that led to success. Senator Susan Collins, R-Maine, explained that a big reason her state made it work was because it had a lot of funding. She noted that the funding in the House bill is one-fifth of what is needed.
Expanding Medicaid Coverage for HCV Treatment
States have been concerned about expanding coverage for hepatitis C virus (HCV) treatments because of the high cost of the newest drugs. However, Pennsylvania has bowed to pressure from advocacy organizations and will expand Medicaid coverage of HCV treatments, reported The Philadelphia Inquirer. Most states have followed the protocol of delaying treatment. Previously in Pennsylvania, patients had to have signs of liver damage before they were approved for treatment; now all patients, regardless of HCV severity, will be covered beginning January 1, 2018.
HIV, Hepatitis C Testing Rates Remain Dismal Among Injection Drug Users
April 17th 2020Despite being at an increased risk for HIV and hepatitis C, persons who inject drugs (PWID) are tested at dismal rates for both: just 8.6% and 7.7%, respectively, according to data from 2010 to 2017. PWID who live in rural communities are more likely to face barriers to adequate testing and care for both diseases.
Read More
Dr Rebekah Gee Offers an Inside Look at Louisiana's Subscription Payment Model for HCV Drugs
May 7th 2019We speak with Dr Rebekah Gee, secretary of the Louisiana Department of Health about the subscription payment model for hepatitis C virus drugs that the state has entered into with Asegua Therapeutics, a subsidiary of Gilead Sciences.
Listen